Media Summary: Mistargeted therapies can cause serious side effects and clinical failures. Learn about using the Membrane Proteome Array to ... Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. However, conventional screening ... Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs.
Webinar Towards Ind Specificity Profiling - Detailed Analysis & Overview
Mistargeted therapies can cause serious side effects and clinical failures. Learn about using the Membrane Proteome Array to ... Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. However, conventional screening ... Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs. Dr. Mark Inman - Regional Respirology Clinical Rounds - May 9, 2023. Join Sundeep Ahluwalia, Chief Product Officer at TDK SensEI, as he explores the future of Overview: qPCR can be a powerful tool for analyzing gene expression. When designed properly, however its strength relies on ...
![[Webinar]Towards IND: Specificity Profiling of Antibody Therapies Using the Membrane Proteome Array](https://i.ytimg.com/vi/uycwUN0mPvY/mqdefault.jpg)
![[GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies](https://i.ytimg.com/vi/RzMgxMnWksk/mqdefault.jpg)
